Higher cancer risk was related to BRCT domain of BRCA1 for breast cancer, and BRC repeats of BRCA2 for ovarian cancer. Parity was a risk-reducing factor among BRCA1/2 mutation carriers. Risk factors can be used for personalized preventive strategies of BRCA1/2 mutation carriers.Park, Ji ...
However, other distinctly different morphologic characteristics between them could be seen. Stones from patient IIa showed irregular in shape and ununiformity in size on stereomicroscopic examination, and scanning electron microscopy displayed the inhomogeneous internal structures with the aggregations of ...
while prostate cancer is the growth of a tumor in the prostate gland due to inherited genetic mutations in genes such asBRCA1,BRCA2,andHOXB13. Thus, this is the key difference between enlarged prostate and prostate cancer. Furthermore, the risk factors for an enlarged...
The key difference between breast cancer and fibroadenoma is their nature. Breast cancer leads to the formation of cancerous lumps in breast tissue, which can spread over time outside the breast, while fibroadenoma leads to the formation of benign or non-cancerous lumps in the breast tissue, w...
The article presents a study which examines the difference of triple negative breast cancer (TNBC), basal-like breast cancer (BLBC) and BRCA1 associated breast cancer (BABC). The study describes the pathology and biology of the three groups of tumor such as the definition of triple negative ...
Basal-like breast cancer was delineated using this methodology and demonstrates significant overlap with so-called triple negative and BRCA1-associated breast carcinomas. This article describes the pathology and biology of these three groups of tumours and examines the relationship between them. ...
Anxiety did not differ significantly between groups. Reactions to materials differed on two items: "seemed to be prepared just for me" (76% TPM vs. 52% NPM; p < 0.001) and "told me what I wanted to know about BRCA1 and 2 testing" (98% TPM vs. 91% NPM; p<0.05). TPMs showed ...